Table: begin end state 1 24 signal peptide 25 850 non-cytoplasmic 851 867 transmembrane 868 870 non-cytoplasmic 871 1073 cytoplasmic
Input: >AO353_05630 FitnessBrowser__pseudo3_N2E3:AO353_05630 MPKRTDIKSILILGAGPIVIGQACEFDYSGAQACKALREEGYRVILVNSNPATIMTDPAM ADATYIEPIKWQTVAKIIEKERPDALLPTMGGQTALNCALDLEREGILEKFGVEMIGANA DTIDKAEDRSRFDKAMKSIGLACPRSGIAHSMEEANAVLEKLGFPCIIRPSFTMGGTGGG IAYNREEFEEICARGLDLSPTKELLIDESLIGWKEYEMEVVRDKKDNCIIVCSIENFDPM GVHTGDSITVAPAQTLTDKEYQILRNASLAVLREIGVETGGSNVQFGICPNTGRMVVIEM NPRVSRSSALASKATGFPIAKVAAKLAVGYTLDELSNDITGGKTPASFEPSIDYVVTKLP RFAFEKFPKADARLTTQMKSVGEVMAIGRTFQESLQKALRGLEVGVCGLDEKLDLSNPES MSVLKRELTVPGAERIWYVADAMRAGMSVEDIFGMTMIDPWFLVQMEDLIKDEEKVKTLG LTSIDRDMMFRLKRKGFSDQRLAKLLGVTEKSLRAHRHKLEVFPVYKRVDTCAAEFATDT AYLYSTYEEECEAAPSGRDKIMILGGGPNRIGQGIEFDYCCVHAALALRDDGYETIMVNC NPETVSTDYDTSDRLYFEPVTLEDVLEIVRVEKPKGVIVQYGGQTPLKLARALEAAGVPI IGTSPDAIDRAEDRERFQQMVQRLNLRQPPNATVRSEDEAIRAAAKIGYPLVVRPSYVLG GRAMEIVYEEEELKRYLREAVQVSNDSPVLLDHFLNCAIEMDVDAVCDGTDVVIGAIMQH IEQAGVHSGDSACSLPPYSLPLHIQDEMREQVKKMALELGVVGLMNVQLALQGEDIYVIE VNPRASRTVPFVSKCIGVSLAMIAARVMAGKTLKEIGFTKEIIPNFYSVKEAVFPFAKFP GVDPILGPEMKSTGEVMGVGDTFGEAFAKAQMGASEVLPTGGTAFISVRDDDKPLVAGVA RDLINLGFEVVATAGTAKLIEAAGLKVRRVNKVTEGRPHVVDMIKNDEVTLIINTTEGRQ SIADSYSIRRNALQHKIYCTTTIAAGEAICEALKFGPEKTVRRLQDLHAGLKA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server